Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|June 8, 2012
Polo-like kinase 1 directs the AMPK-mediated activation of myosin regulatory light chain at the cytokinetic cleavage furrow independently of energy balanceAlejandro Vazquez-Martin, Sílvia Cufí, Cristina Oliveras-Ferraros, et al.
Cell Cycle (Georgetown, Tex.)|March 23, 2010
Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomenaBegoña Martin-Castillo, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
Cell Cycle (Georgetown, Tex.)|October 22, 2009
AMPK: Evidence for an energy-sensing cytokinetic tumor suppressorAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Eugeni Lopez-Bonet, et al.
Cell Cycle (Georgetown, Tex.)|November 5, 2011
mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and agingJavier A Menendez, Luciano Vellon, Cristina Oliveras-Ferraros, et al.
Biochemical and Biophysical Research Communications|November 27, 2008
AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid SynthaseCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Jose Manuel Fernández-Real, et al.
Clinical Chemistry|February 3, 2009
Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancerJavier A Menendez, Alejandro Vazquez-Martin, Francisco Jose Ortega, et al.
Biochemical and Biophysical Research Communications|March 17, 2009
The serine 2481-autophosphorylated form of mammalian Target Of Rapamycin (mTOR) is localized to midzone and midbody in dividing cancer cellsAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Luis Bernadó, et al.
Journal of Cellular Biochemistry|September 25, 2008
The tyrosine kinase receptor HER2 (erbB-2): from oncogenesis to adipogenesisAlejandro Vazquez-Martin, Francisco Jose Ortega-Delgado, Jose Manuel Fernandez-Real, et al.
Breast Cancer Research and Treatment|May 12, 2010
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cellsAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Sonia Del Barco, et al.
Oncoscience|March 31, 2015
The "virgin birth", polyploidy, and the origin of cancerJekaterina Erenpreisa, Kristine Salmina, Anda Huna, et al.
Pageof 8